Practical Experiences of High-Content Screening, London, UK
Event Jun 16
Given the high cost of failure in drug development, it is crucial that researchers have tools that provide high-quality information about drug targets. However, current screening efforts are proving one of industry's most potent bottlenecks requiring further attention. Our unique user-focused event will give you an insight into overcoming challenges in implementation, application and utilising the high content screening technology.
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018